Healthy brain, muscle, eye and heart cells would improve the lives of tens of thousands of people around the world with debilitating¹ mitochondrial diseases. Now, researchers at the Salk Institute have gotten one step closer to making such cures a reality: they've turned cells from patients into healthy, mutation-free stem cells that can then become any cell type. The new approach is described July 15, 2015 in Nature. "Right now, there are no cures for mitochondrial diseases," says senior author Juan Carlos Izpisua Belmonte, professor in Salk's Gene² Expression Laboratory. "Very recently, we've developed ways to prevent these diseases, so it was natural to next ask how we could treat them."

 

Mitochondrial diseases are caused by any of about 200 mutations that affect the genes³ of mitochondria, tiny powerhouses inside nearly every cell of the body. Depending on the affected⁴ genes and cell types, the diseases can cause muscle weakness, liver disease, diabetes⁵, seizures⁶, developmental delays or vision problems. Existing therapies aim to ease the symptoms or slow the progression of the diseases, but can't entirely⁷ cure them. 

 

In their new work, Belmonte and collaborators from around the world collected skin samples from patients with mitochondrial encephalomyopathy or Leigh Syndrome⁸, both severe disorders⁹ that affect the brain and muscles. 

 

The teams began by using current standard protocols¹⁰ to derive¹¹ pluripotent stem cells from the skin cells, a process that resets¹² the cells to their most basic state. 

 

"During the process of stem cell generation, you spontaneously get different types of clones," says Alejandro Ocampo, a research associate in Izpisua Belmonte's lab and one of the authors of the new paper. If the patient cells have an initial mix of healthy and diseased mitochondria, healthy and diseased stem cells will be generated. Then, the stem cells with healthy mitochondria can be picked out.

 

For some patients, though, this straightforward¹³ approach doesn't work; their cells don't have enough--or any--healthy mitochondria to start with. 

 

So the team came up with a second approach: move the nucleus¹⁴ of the patient's skin cells, which contains most of their genes, into a donor¹⁵ egg cell with healthy mitochondria. Then, use the new egg cell to generate pluripotent stem cells. When the researchers did this, they found the healthy mitochondria took over, and healthy, genetically¹⁶ similar cells from the patient were successfully generated. 

 

"In either case, the idea is that we have healthy stem cells, and we know how to convert pluripotent stem cells into different cell types," says Jun Wu, an author of the paper and research associate in Izpisua Belmonte's lab. "They have the potential to give rise to every cell type in the body."

点击收听单词发音